Shenzhen
-
GSK and Shenzhen Neptunus to Develop Vaccines in China
GlaxoSmithKline (GSK) has entered into an agreement to form a Joint Venture (JV) with Shenzhen Neptunus Interlong Bio-Technique (Shenzhen Neptunus), focused on developing and manufacturing influenza vaccines for the Chinese market. The alliance wi…
Shenzhen | 19 June 2009
-
Benda: Majority Owner of Shenzhen SiBiono GeneTech
China-based Benda Pharmaceutical, Inc. announced that through its 95% owned China-based subsidiary, Hubei Tongji Benda Ebei Pharmaceutical, it has acquired 57.57% of Shenzhen SiBiono GeneTech Co., Ltd., maker of Gendicine cancer treatment, the world…
Shenzhen | 19 April 2007
